PME
Pro Medicus Ltd
$164.37
▲ +1.37%
Market cap
$17.17B
Turnover
$12,620,057
Last price
$164.37
Day change
+1.37%
Announcements
14
Range, past year
Open 308.2 · Low 107.7 · Now 164.3 · High 336.0
Open PME in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
PME momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-29.
Momentum quality
31/100
Wyckoff phase
Accumulation1d
Trend stage
Distribution
1 Day
+1.4%
1 Week
+0.0%
1 Month
-8.4%
1 Year
-45.5%
RSI
43
Avg daily range
3.4%
Pro Medicus Ltd scores 31 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Distribution.
On the Wyckoff cycle it sits in Accumulation, where it has been for 1 trading day. The weekly timeframe reads Accumulation, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -24.7%
- Risk rating: High
- Composite downside risk elevated
PME announcements
Recent price-sensitive releases.
- 2026-08-21 PME signs 7-year, A$25M contract with Valley Health Progress Report
- 2026-08-18 PME FY26 results presentation Company Presentation | Preliminary Final Report
- 2026-08-18 CEO Interview FY26 Results Preliminary Final Report | Chair's Address - Other
- 2026-08-18 PME Full Year Results Preliminary Final Report
- 2026-08-18 Preliminary Final Report FY26 (Appendix 4E) Preliminary Final Report | Dividend Record Date | Dividend Pay Date | Dividend Rate
- 2026-08-17 PME signs Convertible Note agreement with Echo IQ Progress Report
- 2026-08-12 PME signs A$23M, 7-year contract with St Luke's Health Progress Report
More Health Care stocks
Most traded in the same sector.